Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 17,950 shares at $24.50 ($440K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($440k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.50 | 8,975 | $220K | 50.0% |
| 2 | $24.50 | 8,975 | $220K | 50.0% |
| Total | $24.50 avg | 17,950 | $440K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-19 | $172K | — | Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |